Press "Enter" to skip to content

New patent for Azurity drug EPANED

3
Copyright © DrugPatentWatch. Originally published at New patent for Azurity drug EPANED

Annual Drug Patent Expirations for EPANED
Annual Drug Patent Expirations for EPANED

Epaned is a drug marketed by Azurity and Silvergate Pharms and is included in two NDAs. It is available from one supplier. There are eight patents protecting this drug and two Paragraph IV challenges.

EPANED drug price trends.

Drug patent litigation for EPANED.

This drug has three patent family members in three countries.

The generic ingredient in EPANED is enalapril maleate. One supplier is listed for this compound. Additional details are available on the enalapril maleate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Azurity drug EPANED

Comments are closed.

Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!